The Japan Times - China's health system faces raft of challenges as Omicron hits

EUR -
AED 4.276798
AFN 76.973093
ALL 96.541337
AMD 443.660189
ANG 2.0846
AOA 1067.888653
ARS 1669.958677
AUD 1.752514
AWG 2.096182
AZN 1.984351
BAM 1.955625
BBD 2.34549
BDT 142.477215
BGN 1.956439
BHD 0.439061
BIF 3440.791247
BMD 1.164546
BND 1.508565
BOB 8.047278
BRL 6.334667
BSD 1.164496
BTN 104.702605
BWP 15.471612
BYN 3.348
BYR 22825.091832
BZD 2.34209
CAD 1.610159
CDF 2599.265981
CHF 0.936209
CLF 0.027366
CLP 1073.571668
CNY 8.233458
CNH 8.232219
COP 4424.302993
CRC 568.848955
CUC 1.164546
CUP 30.860456
CVE 110.255106
CZK 24.203336
DJF 207.371392
DKK 7.470448
DOP 74.533312
DZD 151.505205
EGP 55.295038
ERN 17.468183
ETB 180.629892
FJD 2.632397
FKP 0.873977
GBP 0.872973
GEL 3.138497
GGP 0.873977
GHS 13.246811
GIP 0.873977
GMD 85.012236
GNF 10119.091982
GTQ 8.9202
GYD 243.638138
HKD 9.065875
HNL 30.671248
HRK 7.535429
HTG 152.446321
HUF 381.994667
IDR 19435.740377
ILS 3.768132
IMP 0.873977
INR 104.760771
IQD 1525.563106
IRR 49041.926882
ISK 149.038983
JEP 0.873977
JMD 186.393274
JOD 0.825709
JPY 180.924237
KES 150.636483
KGS 101.839952
KHR 4662.581612
KMF 491.43861
KPW 1048.137083
KRW 1716.311573
KWD 0.357481
KYD 0.970513
KZT 588.927154
LAK 25252.733992
LBP 104283.942272
LKR 359.197768
LRD 204.961608
LSL 19.736529
LTL 3.438601
LVL 0.704422
LYD 6.330432
MAD 10.755735
MDL 19.814222
MGA 5194.533878
MKD 61.634469
MMK 2445.172268
MNT 4132.506664
MOP 9.338362
MRU 46.438833
MUR 53.651052
MVR 17.938355
MWK 2019.3188
MXN 21.165153
MYR 4.787492
MZN 74.426542
NAD 19.736529
NGN 1688.68458
NIO 42.856154
NOK 11.767853
NPR 167.523968
NZD 2.015483
OMR 0.447772
PAB 1.164595
PEN 3.914449
PGK 4.941557
PHP 68.66747
PKR 326.476804
PLN 4.229804
PYG 8009.281302
QAR 4.244719
RON 5.092096
RSD 117.389466
RUB 88.93302
RWF 1694.347961
SAR 4.370508
SBD 9.584899
SCR 15.774978
SDG 700.4784
SEK 10.946786
SGD 1.508673
SHP 0.873711
SLE 27.603998
SLL 24419.93473
SOS 664.340387
SRD 44.985272
STD 24103.740676
STN 24.497802
SVC 10.190086
SYP 12876.900539
SZL 19.72123
THB 37.119932
TJS 10.684641
TMT 4.087555
TND 3.416093
TOP 2.803946
TRY 49.523506
TTD 7.894292
TWD 36.437508
TZS 2841.64501
UAH 48.888813
UGX 4119.630333
USD 1.164546
UYU 45.545913
UZS 13931.74986
VES 296.437311
VND 30697.419423
VUV 142.156724
WST 3.247609
XAF 655.898144
XAG 0.019993
XAU 0.000277
XCD 3.147243
XCG 2.098812
XDR 0.815727
XOF 655.898144
XPF 119.331742
YER 277.802752
ZAR 19.711451
ZMK 10482.311144
ZMW 26.923584
ZWL 374.983176
  • RBGPF

    0.0000

    78.35

    0%

  • JRI

    0.0400

    13.79

    +0.29%

  • BCC

    -1.2100

    73.05

    -1.66%

  • BCE

    0.3300

    23.55

    +1.4%

  • CMSD

    -0.0700

    23.25

    -0.3%

  • SCS

    -0.0900

    16.14

    -0.56%

  • GSK

    -0.1600

    48.41

    -0.33%

  • NGG

    -0.5000

    75.41

    -0.66%

  • CMSC

    -0.0500

    23.43

    -0.21%

  • RELX

    -0.2200

    40.32

    -0.55%

  • AZN

    0.1500

    90.18

    +0.17%

  • RYCEF

    -0.0500

    14.62

    -0.34%

  • VOD

    -0.1630

    12.47

    -1.31%

  • RIO

    -0.6700

    73.06

    -0.92%

  • BTI

    -1.0300

    57.01

    -1.81%

  • BP

    -1.4000

    35.83

    -3.91%

China's health system faces raft of challenges as Omicron hits
China's health system faces raft of challenges as Omicron hits

China's health system faces raft of challenges as Omicron hits

China is battling its biggest spike in coronavirus cases since the start of the pandemic, with millions under lockdown and the healthcare system feeling the pressure.

Text size:

One of the last countries sticking to a zero-Covid strategy, China aims to stamp out every infection with strict lockdowns and by sending all cases to secure facilities.

That is placing a strain on China's already under-pressure medical system, as the highly transmissible Omicron variant rapidly moves through the population.

Here are some of China's key challenges in the fight against Covid:

- Vaccination rates -

Beijing says more than 1.2 billion people in China had received two doses of a Covid vaccine by mid-March -- nearly 90 percent of the population.

It has also launched a booster campaign but more than half of the population has yet to receive a third shot.

A major challenge is protecting the elderly, with only around half of Chinese people aged above 80 double-vaccinated and fewer than a fifth having received a booster.

Among the over-60s, just over half have received a third shot.

Officials have launched a fresh push to encourage older people to get a third dose, after hospitals in Hong Kong were overwhelmed by a wave of severe cases -- mostly unvaccinated elderly patients.

China is using homegrown vaccines and has not approved any foreign-made shots, but it has given "conditional" approval to Pfizer's Covid-19 drug Paxlovid.

Chinese vaccines have shown a lower rate of efficacy in studies compared with many foreign jabs.

However, several Chinese vaccine makers have recently been given the go-ahead for clinical trials on a domestically-made mRNA Covid jab -- the same technology as the Pfizer/BioNTech and Moderna shots.

- Hospitals stretched -

China's healthcare system was understaffed and struggling to cope with its huge and ageing population even before the pandemic.

According to the National Health Commission, China has only 2.9 general practitioners per 10,000 people. Britain has around the same number for every 1,000 people.

Some Chinese regions are woefully under-resourced.

In Jilin province, site of a recent Covid cluster, authorities said there were only 22,880 hospital beds for a population of 24 million.

Peking University researchers have warned that China could suffer a "colossal outbreak" that would quickly overwhelm its medical system if the authorities relaxed restrictions to a similar degree as in Europe and the United States.

It would likely lead to hundreds of thousands of new cases a day, the researchers said.

- Urban-rural divide -

Despite huge reductions in rural poverty, there are still significant differences in access to healthcare between the countryside and cities.

Much of China's wealth, equipment and expertise is based in top-tier cities where richer residents can choose between a range of hospitals including international clinics.

According to a National Health Commission report last year, China had only 1.6 medical workers per 1,000 people in rural areas and just 1.5 hospital beds.

Although nearly 40 percent of the population lives in the countryside, rural China had a total of only 1.4 million hospital beds.

Rural Chinese who migrate to cities for work also struggle to access healthcare in the cities due to red tape.

- Maintaining 'zero-Covid' -

Despite being China's most developed city, Shanghai has descended into crisis as authorities scramble to find enough beds for people who test positive.

Authorities have said 130,000 new beds are ready or under construction at makeshift venues.

About 40,000 beds are being set up at Shanghai's landmark National Exhibition and Convention Center.

But most are currently filled by people with mild symptoms or none at all.

Meanwhile, Shanghai residents under lockdown have complained about a lack of access to food and medicines unrelated to Covid.

"Draconian, heavy-handed zero-Covid control measures" have overwhelmed the medical system, according to Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relations in New York.

This is "an outcome that the zero-Covid strategy is supposed to avoid", he told AFP.

Two thousand soldiers and 38,000 medical workers from around the country have been sent to Shanghai as reinforcements.

At least two asthma patients died after reportedly being refused medical services due to Covid rules.

As pressure on the system grows, some close contacts of patients are being allowed to quarantine at home, while rapid home testing kits have been deployed for the first time.

Shanghai health commission chief Wu Jinglei said this week that although the city had 50 percent more ambulances on the road than before the outbreak, it still could not handle all the requests for medical help.

H.Nakamura--JT